DLHAX
Price
$27.99
Change
-$0.22 (-0.78%)
Updated
Nov 19 closing price
Net Assets
704.16M
FSPHX
Price
$30.27
Change
+$0.15 (+0.50%)
Updated
Nov 19 closing price
Net Assets
6.22B
Interact to see
Advertisement

DLHAX vs FSPHX

Header iconDLHAX vs FSPHX Comparison
Open Charts DLHAX vs FSPHXBanner chart's image
Macquarie Healthcare A
Price$27.99
Change-$0.22 (-0.78%)
VolumeN/A
Net Assets704.16M
Fidelity Select Health Care
Price$30.27
Change+$0.15 (+0.50%)
VolumeN/A
Net Assets6.22B
DLHAX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
DLHAX vs. FSPHX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHAX is a Hold and FSPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. DLHAX (704M). DLHAX pays higher dividends than FSPHX: DLHAX (0.09) vs FSPHX (0.02). DLHAX was incepted earlier than FSPHX: DLHAX (18 years) vs FSPHX (44 years). DLHAX (1.26) is less costly to investors than FSPHX (0.63). FSPHX is a more actively managed with annual turnover of: 40.00 vs. DLHAX (5.00). FSPHX has a lower initial minimum investment than DLHAX: FSPHX (0) vs DLHAX (1000). DLHAX annual gain was more profitable for investors over the last year : 4.38 vs. FSPHX (0.02). DLHAX return over 5 years is better than : 0.14 vs. FSPHX (-8.84).
DLHAXFSPHXDLHAX / FSPHX
Total Expense Ratio1.210.63192%
Annual Report Gross Expense Ratio1.260.63200%
Fund Existence18 years44 years-
Gain YTD17.85310.532170%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets704M6.22B11%
Annual Yield % from dividends0.090.02554%
Returns for 1 year4.380.0225,931%
Returns for 3 years4.4210.4742%
Returns for 5 years0.14-8.84-2%
Returns for 10 years37.0139.3494%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVTCX55.320.24
+0.44%
Calamos Growth & Income C
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.66N/A
N/A
Bruce
REMVX11.03N/A
N/A
RBC Emerging Markets Value Equity I
SPMHX8.48N/A
N/A
Invesco SteelPath MLP Alpha R5